These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22187677)

  • 1. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1.
    Wesołowska O
    Acta Biochim Pol; 2011; 58(4):433-48. PubMed ID: 22187677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
    Wesołowska O; Molnar J; Ocsovszki I; Michalak K
    In Vivo; 2009; 23(6):943-7. PubMed ID: 20023237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal.
    Michalak K; Wesolowska O; Motohashi N; Molnar J; Hendrich AB
    Curr Drug Targets; 2006 Sep; 7(9):1095-105. PubMed ID: 17017888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.
    Boumendjel A; Baubichon-Cortay H; Trompier D; Perrotton T; Di Pietro A
    Med Res Rev; 2005 Jul; 25(4):453-72. PubMed ID: 15834856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonostilbenes from Sophora alopecuroides L. as multidrug resistance associated protein 1 (MRP1) inhibitors.
    Ni K; Yang L; Wan C; Xia Y; Kong L
    Nat Prod Res; 2014; 28(23):2195-8. PubMed ID: 24956120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
    Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1.
    Wesołowska O; Wiśniewski J; Sroda K; Krawczenko A; Bielawska-Pohl A; Paprocka M; Duś D; Michalak K
    Eur J Pharmacol; 2010 Oct; 644(1-3):32-40. PubMed ID: 20633549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can flavonoids from honey alter multidrug resistance?
    Jaganathan SK
    Med Hypotheses; 2011 Apr; 76(4):535-7. PubMed ID: 21247706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5).
    Wu CP; Calcagno AM; Hladky SB; Ambudkar SV; Barrand MA
    FEBS J; 2005 Sep; 272(18):4725-40. PubMed ID: 16156793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer.
    Dhasmana D; Singh A; Shukla R; Tripathi T; Garg N
    Sci Rep; 2018 Aug; 8(1):11973. PubMed ID: 30097643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRP1 and its role in anticancer drug resistance.
    Lu JF; Pokharel D; Bebawy M
    Drug Metab Rev; 2015; 47(4):406-19. PubMed ID: 26541366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance.
    Tsakovska I; Pajeva I
    Curr Drug Targets; 2006 Sep; 7(9):1123-34. PubMed ID: 17017890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenothiazine maleates stimulate MRP1 transport activity in human erythrocytes.
    Wesołowska O; Mosiadz D; Motohashi N; Kawase M; Michalak K
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):52-8. PubMed ID: 16364236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents.
    Ojima I; Borella CP; Wu X; Bounaud PY; Oderda CF; Sturm M; Miller ML; Chakravarty S; Chen J; Huang Q; Pera P; Brooks TA; Baer MR; Bernacki RJ
    J Med Chem; 2005 Mar; 48(6):2218-28. PubMed ID: 15771464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1).
    Sauna ZE; Peng XH; Nandigama K; Tekle S; Ambudkar SV
    Mol Pharmacol; 2004 Mar; 65(3):675-84. PubMed ID: 14978246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
    Wesolowska O; Molnár J; Motohashi N; Michalak K
    Anticancer Res; 2002; 22(5):2863-7. PubMed ID: 12530010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of multidrug resitance by natural substances from plants.
    Molnár J; Engi H; Hohmann J; Molnár P; Deli J; Wesolowska O; Michalak K; Wang Q
    Curr Top Med Chem; 2010; 10(17):1757-68. PubMed ID: 20645919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1.
    Chang XB
    Cancer Metastasis Rev; 2007 Mar; 26(1):15-37. PubMed ID: 17295059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New phenothiazine-type multidrug resistance modifiers: anti-MDR activity versus membrane perturbing potency.
    Hendrich AB; Wesołowska O; Motohashi N; Molnár J; Michalak K
    Biochem Biophys Res Commun; 2003 May; 304(2):260-5. PubMed ID: 12711308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
    Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G
    Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.